P21 Research Reference

Catalog classification, reference sizes, lab math links, and source-backed data. Educational use only — not medical advice.

Researched for: P21 evidence and protocol review

Neuro Research peptide Lyophilized verified

Also known as: P021, P21 peptide

Quick Facts

Reference Sizes
2 mg, 5 mg, 10 mg
Calculator
Preset available
Storage
Use source-label storage wording. Track lot, storage location, and open/reconstitution date.
Solubility
Lyophilized; reconstitute in sterile water for SC; saline for intranasal

Catalog Description

P21 is a peptide derived from p21 (Cip1/Waf1), a cyclin-dependent kinase inhibitor protein, studied in rodent models for effects on neuroinflammation, synaptic plasticity, and cognitive function. In aged Fischer rats, P21 counteracted age-related declines in learning and memory, reportedly by restoring hippocampal and cortical neurogenesis and upregulating brain-derived neurotrophic factor (BDNF) signaling. Separate preclinical work in 3xTg-AD transgenic mice found P21 attenuated tau and, to a lesser extent, amyloid-beta pathology, with effects proposed to act through the BDNF/TrkB/PI3-K/AKT/GSK3-beta pathway. All available evidence is preclinical (rodent); no human clinical trials have been published, and mechanistic details (specific receptor targets, optimal dosing, exposure route) remain incompletely characterized.

Catalog descriptions reflect research context only. Not a medical claim or treatment recommendation.

Research Profile

Half-Life
Not characterized in humans; adamantylated glycine was added to improve stability and blood-brain-barrier exposure
Onset
Cognitive/behavioral effects measured over weeks of repeated dosing in rodent studies
Administration Routes (Research)
Oral dietary exposure in mouse studies; no validated human or SC route

Reported Research Effects

Reported Research Side Effects

Data source: Primary literature, regulator records, trial registries, and identity-specific evidence search

Reflects preclinical/research literature context only. Not a medical claim, dosing instruction, or treatment recommendation.

Research Protocols Reported in the Literature

Research Notes

The catalog name P21 is often used for P021, the CNTF-derived peptidergic compound Ac-DGGL(A)G-NH2. All located dosing evidence is preclinical and oral-in-feed; no human or injectable protocol was found.

Supplementary research context only. Not medical advice or a treatment recommendation.

Sources

P021 long-term 3xTg-AD mouse prevention study — PubMed (NIH)
https://pubmed.ncbi.nlm.nih.gov/28655344/
P021 CDKL5-deficiency mouse study — PubMed (NIH)
https://pubmed.ncbi.nlm.nih.gov/39592934/
P021 chronic 3xTg-AD mouse treatment study — PubMed (NIH)
https://pubmed.ncbi.nlm.nih.gov/25046994/

Suggest a community source

Found a relevant Reddit or forum thread about this compound? Suggest it below. Every suggestion is reviewed by an editor before it appears -- nothing is published automatically.

Related Research Articles

Published articles on this site that mention P21 or one of its catalog aliases.

Related Research Tools

Research Use Only. All content is for educational and research reference only. Not medical advice, a treatment recommendation, or guidance on human use. Compounds are not FDA-approved drugs unless specifically noted.

Scroll to Top